Koichiro Minauchi

483 total citations
17 papers, 267 citations indexed

About

Koichiro Minauchi is a scholar working on Hematology, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Koichiro Minauchi has authored 17 papers receiving a total of 267 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Hematology, 6 papers in Pathology and Forensic Medicine and 6 papers in Oncology. Recurrent topics in Koichiro Minauchi's work include Acute Myeloid Leukemia Research (6 papers), Lymphoma Diagnosis and Treatment (6 papers) and Chronic Lymphocytic Leukemia Research (3 papers). Koichiro Minauchi is often cited by papers focused on Acute Myeloid Leukemia Research (6 papers), Lymphoma Diagnosis and Treatment (6 papers) and Chronic Lymphocytic Leukemia Research (3 papers). Koichiro Minauchi collaborates with scholars based in Japan and United States. Koichiro Minauchi's co-authors include Masaya Mukai, Takanori Teshima, Shuichi Ota, Tomoyuki Endo, Masato Obara, Akio Mori, Koh Izumiyama, Daigo Hashimoto, Norihiro Sato and Minoru Kanaya and has published in prestigious journals such as Blood, British Journal of Haematology and American Journal of Hematology.

In The Last Decade

Koichiro Minauchi

15 papers receiving 266 citations

Peers

Koichiro Minauchi
Nashla Barroso United States
J. Léone France
Yuichiro Nawa Japan
Maria-Elena Cabezudo Spain
A. Dadban France
Christopher M. Bearden United States
Meghan C. Thompson United States
Emre Tekgündüz Türkiye
A Andriani Italy
H. Deicher Germany
Nashla Barroso United States
Koichiro Minauchi
Citations per year, relative to Koichiro Minauchi Koichiro Minauchi (= 1×) peers Nashla Barroso

Countries citing papers authored by Koichiro Minauchi

Since Specialization
Citations

This map shows the geographic impact of Koichiro Minauchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Koichiro Minauchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Koichiro Minauchi more than expected).

Fields of papers citing papers by Koichiro Minauchi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Koichiro Minauchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Koichiro Minauchi. The network helps show where Koichiro Minauchi may publish in the future.

Co-authorship network of co-authors of Koichiro Minauchi

This figure shows the co-authorship network connecting the top 25 collaborators of Koichiro Minauchi. A scholar is included among the top collaborators of Koichiro Minauchi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Koichiro Minauchi. Koichiro Minauchi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Tamura, Tomokazu, Mutsumi Takahata, Takashi Ishio, et al.. (2023). Prolonged shedding of viable SARS‐CoV ‐2 in immunocompromised patients with haematological malignancies: A prospective study. British Journal of Haematology. 204(3). 815–820. 11 indexed citations
2.
Senjo, Hajime, Kenji Hirata, Koh Izumiyama, et al.. (2020). High metabolic heterogeneity on baseline 18FDG-PET/CT scan as a poor prognostic factor for newly diagnosed diffuse large B-cell lymphoma. Blood Advances. 4(10). 2286–2296. 37 indexed citations
3.
Saito, Takeshi, Yoshihiro Hatta, Fumihiko Hayakawa, et al.. (2020). Combination of clofarabine, etoposide, and cyclophosphamide in adult relapsed/refractory acute lymphoblastic leukemia: a phase 1/2 dose-escalation study by the Japan Adult Leukemia Study Group. International Journal of Hematology. 113(3). 395–403. 3 indexed citations
4.
Matsukawa, Toshihiro, Minoru Kanaya, Koh Izumiyama, et al.. (2020). Validation and comparison of prognostic values of GNRI, PNI, and CONUT in newly diagnosed diffuse large B cell lymphoma. Annals of Hematology. 99(12). 2859–2868. 45 indexed citations
5.
6.
Senjo, Hajime, Kenji Hirata, Koh Izumiyama, et al.. (2019). High Metabolic Heterogeneity on Baseline 18F-FDG PET/CT Predicts Worse Prognosis of Newly Diagnosed Diffuse Large B-Cell Lymphoma. Blood. 134(Supplement_1). 488–488. 3 indexed citations
7.
Nakasone, Hideki, Kiriko Terasako‐Saito, Atsushi Wake, et al.. (2017). Targeting complete response with upfront bortezomib consolidation versus observation after the achievement of complete response following autologous transplantation for multiple myeloma (TUBA study). Hematological Oncology. 36(1). 202–209. 1 indexed citations
8.
Minauchi, Koichiro, Takahide Ara, Atsushi Yasumoto, et al.. (2015). [Serum ALP elevation early after treatment is a predictor for response in myeloma patients treated with bortezomib].. PubMed. 56(8). 1064–8.
9.
10.
Minauchi, Koichiro, Kazuki Koizumi, Makoto Kondō, et al.. (2011). [Remission induced by dose-reduction of immunosuppressants alone in a patient with post-transplant lymphoproliferative disorder of central nervous system origin].. PubMed. 52(5). 272–7. 1 indexed citations
11.
Minauchi, Koichiro, Akio Shigematsu, Masanobu Nakata, et al.. (2011). Monosomal Karyotype in Myeloid Malignancies Is Prognostically Worse Even After Allogeneic Hematopoietc Stem Cell Transplantaion; Results From Two Transplant Centers,. Blood. 118(21). 4154–4154. 1 indexed citations
12.
Minauchi, Koichiro, Shunji Takahashi, Makoto Kondo, et al.. (2010). The Nosocomial Transmission of Helicobacter cinaedi Infections in Immunocompromised Patients. Internal Medicine. 49(16). 1733–1739. 44 indexed citations
13.
Minauchi, Koichiro, Mitsufumi Nishio, Tomoo Itoh, et al.. (2006). Hepatosplenic alpha/beta T cell lymphoma presenting with cold agglutinin disease. Annals of Hematology. 86(2). 155–157. 4 indexed citations
14.
15.
Takami, Akiyoshi, Hirokazu Okumura, Hirohito Yamazaki, et al.. (2005). Prospective Trial of High-Dose Chemotherapy Followed by Infusions of Peripheral Blood Stem Cells and Dose-Escalated Donor Lymphocytes for Relapsed Leukemia after Allogeneic Stem Cell Transplantation. International Journal of Hematology. 82(5). 449–455. 26 indexed citations
16.
Endo, Tomoyuki, Norihiro Sato, K Koizumi, et al.. (2004). Localized relapse in bone marrow of extremities after allogeneic stem cell transplantation for acute lymphoblastic leukemia. American Journal of Hematology. 76(3). 279–282. 33 indexed citations
17.
Minauchi, Koichiro, et al.. (2004). Primary plasma cell leukemia (IgD-λ) with hyperammonemia. Nihon Naika Gakkai Zasshi. 93(1). 139–141. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nashla Barroso Breakdown of academic impact, for papers by J. Léone Breakdown of academic impact, for papers by Yuichiro Nawa Breakdown of academic impact, for papers by Maria-Elena Cabezudo Breakdown of academic impact, for papers by A. Dadban Breakdown of academic impact, for papers by Christopher M. Bearden Breakdown of academic impact, for papers by Meghan C. Thompson Breakdown of academic impact, for papers by Emre Tekgündüz Breakdown of academic impact, for papers by A Andriani Breakdown of academic impact, for papers by H. Deicher
Rankless by CCL
2026